We used WNT3A as ligand to stimulate Wnt/β-catenin signaling because Wnt3a has been reported to promote proliferation, differentiation, migration, and self-renewal in numerous solid cancers, including CRC [38]. Here, WNT3A is linked to colorectal carcinoma.